NCT04687852

Brief Summary

Primary dysmenorrhea is a common problem in women. Women use many treatment methods to deal with primary dysmenorrhea. Therefore, this study aims to find the most effective treatment by determining the effectiveness of conservative and non-conservative treatment in women with primary dysmenorrhea. Another aim of the study is to generalize the use of conservative treatment methods in the treatment of primary dysmenorrhea.On the other hand, it aims to spread the telerehabilitation method, which allows the global Covid 19 outbreak to be maintained remotely online, in the world and in our country.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 10, 2020

Completed
19 days until next milestone

First Posted

Study publicly available on registry

December 29, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

July 9, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 9, 2021

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2021

Completed
Last Updated

May 24, 2022

Status Verified

June 1, 2021

Enrollment Period

5 months

First QC Date

December 10, 2020

Last Update Submit

May 23, 2022

Conditions

Keywords

Pelvic FloorDysmenorrhea PrimaryDrug therapyTelerehabilitationAcupressure

Outcome Measures

Primary Outcomes (4)

  • Demographic Information Form

    Participants age, height, weight, educational status, marital status, exercise habits will be recorded. In addition, sociodemographic information, clinical features such as background and family history; Information on menarche age, average cycle duration and menstruation duration, and methods of coping with dysmenorrhea were recorded.

    5 minutes

  • Visual Analogue Scale (VAS)

    The Visual Analogue Scale (VAS) is used to convert non-numerical values to digital. The value 0 means I have no pain, 10 means I have unbearable pain. The person marks his pain on this ruler. It measures the intensity of the pain.

    2 minutes

  • McGill Pain Questionnaire

    The characteristic of pain felt by the patients during menstruation was evaluated using the McGill Pain Questionnaire-Short Form,With the McGill Melzack Pain Questionnaire, the location of the pain, the feeling it creates in the individual, its relationship with time, its severity and the level of viable pain for the individual are determined. High score indicates high level of pain

    5 minutes

  • Ultrasonography (US)

    Ultrasonography is a soft tissue examination method.Its biggest advantages are that it is an easily accessible method and does not contain ionizing radiation. In the evaluation by ultrasonography, dysmenorrhea due to organic problems will be evaluated and excluded by the obstetrician.

    5 minutes

Secondary Outcomes (1)

  • Menstrual Attitude Questionnaire

    5 minutes

Study Arms (5)

Focused Pelvic Floor Exercise with Motor ImageryTechnique Group

EXPERIMENTAL

5 minute-Meditation Therapy 10 minute-Progressive Relaxation training ( Bernstein-Borkovec Method) 5 min - Breathing Exercises (Diaphragmatic Breathing Exercise, Pursed lip breathing Exercise) 35 min -Motor Imagery Technique Focused Pelvic Floor Exercises-MOPEXE 5 min - Meditation Therapy Twice a week for 60 minutes 12 weeks Participants will be evaluated online at the beginning of the research and at the end of the 12-week program.

Other: Conservative and Non-conservative treatments

Nonsteroidal Anti-Inflammatory Drug(NSAID) Group

ACTIVE COMPARATOR

Naproxen Sodium 550 mg film-coated tablet prescribed by the physician will be given to patients. During the menstrual period, 1 or 2 times a day will be used depending on the pain of the patient. Treatment time; 12 weeks.

Other: Conservative and Non-conservative treatments

Diosmin Group

OTHER

Diosmin (90%) 500 mg film-coated tablets prescribed by the physician will be given to patients. During the menstrual period, 1 or 2 times a day will be used depending on the patient's pain. Treatment time; 12 weeks.

Other: Conservative and Non-conservative treatments

Acupressure Group

EXPERIMENTAL

4 acupuncture points will be applied twice a day for 12 weeks. These points are; LI4, CV4, CV6, SP6 .

Other: Conservative and Non-conservative treatments

Control Group

NO INTERVENTION

Participants will not be treated.

Interventions

This program includes Focused Pelvic Floor with Motor Imagery Technique Group ,Nonsteroidal Anti-Inflammatory Drug Group, Diosmin Group, Acupressure Group (LI-4 (Bilateral), CV-6, CV-4, SP-6 (Bilateral). It is aimed to determine the most effective treatment among these groups.

Acupressure GroupDiosmin GroupFocused Pelvic Floor Exercise with Motor ImageryTechnique GroupNonsteroidal Anti-Inflammatory Drug(NSAID) Group

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Over the age of 18 whose menstrual cycle continues,
  • Primary dysmenorrhea was diagnosed by the obstetrician by ultrasonographic evaluation.
  • Participants who agree to participate in the study will be included.
  • Participants in the diosmin group who were prescribed diosmin by the physician
  • Participants in the NSAI group who were prescribed an NSAI by the physician

You may not qualify if:

  • Receiving hormone therapy
  • Those receiving psychiatric treatment for stress disorder or anxiety
  • Intrauterine contraceptive device
  • Using birth control pills
  • Women diagnosed with secondary dysmenorrhea
  • With neurological deficits
  • Patients who were not suitable for NSAI and Diosmin treatment by the physician were excluded by the physician and were not included in our study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gizem BOZTAŞ

Istanbul, Kavacık, 34040, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Gizem BOZTAŞ ELVERİŞLİ, Phd

    Istanbul Medipol Üniversitesi

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 10, 2020

First Posted

December 29, 2020

Study Start

July 9, 2021

Primary Completion

December 9, 2021

Study Completion

December 10, 2021

Last Updated

May 24, 2022

Record last verified: 2021-06

Locations